
B Heppy
The Cost of Survival: Navigating Hepatitis B Treatment in America
In this episode, Bright and Anousha chat with Carl Schmid, Executive Director of the HIV+Hepatitis Policy Institute, about the financial challenges people living with hepatitis B face in the U.S., including high medication costs, insurance barriers, and the ongoing struggle to access affordable, life-saving treatment. Note: Carl also shared an important update that at least one widely used hepatitis B medication is now available through Trump Rx for about $20 per month, offering a potentially more affordable option for some patients. Support the show Our website: www.hepb.org Support B Heppy! Social Media: Instagram - Twitter - Facebook






